DigiNepal
Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.